The Claim
Long-term cotrimoxazole prophylaxis is associated with metabolic acidosis in renal transplant recipients due to inhibition of renal tubular sodium channels, which impairs hydrogen and potassium excretion and contributes to type IV renal tubular acidosis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Long-term use of cotrimoxazole in people who have received a kidney transplant is linked to metabolic acidosis caused by reduced excretion of hydrogen and potassium ions in the kidney tubules, leading to type IV renal tubular acidosis.
See the scientific wording
Long-term cotrimoxazole prophylaxis is associated with metabolic acidosis in renal transplant recipients, likely due to its inhibition of renal tubular sodium channels, which impairs hydrogen and potassium excretion, contributing to type IV renal tubular acidosis.
Cotrimoxazole blocks sodium channels in the kidney's collecting duct, which reduces the electrical gradient needed to push potassium and acid out of the blood and into the urine. As a result, potassium builds up in the blood and acid remains trapped, causing high potassium levels and low blood pH.
What the research says
1 studyStudy: Post-Renal Transplant Metabolic Acidosis: A Neglected Entity
This study found that kidney transplant patients taking cotrimoxazole for a long time were more likely to have too much acid in their blood, even when their kidneys were still working well — which matches the claim that the drug causes this problem by messing up kidney tubules.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.